Mass. Medicaid puts Elidel, Protopic on prior authorization
Executive Summary
Massachusetts Medicaid will require prior authorization for Novartis' Elidel (pimecrolimus) and Astellas' Protopic (tacrolimus) effective Aug. 1. Decision was prompted by FDA's March public health advisory on the topical eczema agents, including a request that labeling add a "black box" warning to reflect potential cancer risk (1"The Pink Sheet" March 14, 2005, p. 18). MassHealth says it wanted to ensure that the agents are used as second-line therapy and not in children under two...
You may also be interested in...
Elidel, Protopic “Black Box” Could Be Test Of FDA’s Labeling Authority
FDA's proposal to add a "black box" to labeling of the eczema treatments Elidel and Protopic could be a high-profile test of the agency's ability to change product labeling following recent congressional discussion of the agency's authority
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.